Key facts
- It has raised $14.5M; the latest was Later Stage VC ($14.5M) in Apr 2026.
- Notable investors include Baidu Ventures, CAS Investment Management, China Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for MOPTIM
- ·The full record, as it builds
Funding rounds
No funding rounds for MOPTIM are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MOPTIM
Manufacturer of ophthalmic diagnostic and imaging equipment designed to enhance eye disease detection and clinical evaluation. The company offers optical coherence tomography systems, AI-assisted imaging analysis, high-speed scanning technology, and intelligent diagnostic devices, enabling ophthalmologists and healthcare providers to achieve accurate diagnosis and improved clinical efficiency.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2003
- Website
- moptim.cn/
- Ownership
- Privately Held (backing)
MOPTIM doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MOPTIM shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MOPTIM in its N-PORT filings yet. We sweep new filings monthly.